Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GlaxoSmithKline Aktiebolag
AB
Active
Org 5562366343
Råsundavägen 12, 169 67
Solna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1983
100-199 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
GlaxoSmithKline Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
326M
652M
978M
1B
919M
2020
881M
2021
928M
2022
1.1B
2023
1.1B
2024
EBITDA
SEK millions
0M
10M
21M
31M
41M
25M
2020
29M
2021
30M
2022
34M
2023
36M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
919 193
881 073
928 044
1 073 081
1 134 201
Staff expenses
—
—
—
—
—
EBITDA
24 539
28 689
29 753
33 908
35 604
Depreciation & amort.
—
—
—
—
—
EBIT
24 539
28 689
29 753
33 908
35 604
Net financials
−692
−384
−142
−178
−3 007
Profit before tax
25 588
30 967
32 181
34 153
32 597
Tax
−6 076
−6 824
−7 452
−8 197
−7 813
Net profit
19 512
24 143
24 729
25 956
24 784
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
400 972
375 813
353 842
343 580
437 617
Equity
86 173
90 816
91 545
93 001
91 829
Long-term debt
0
0
0
0
0
Short-term debt
304 859
275 635
258 638
249 651
344 860
Total debt
304 859
275 635
258 638
249 651
344 860
Financial ratios
5-year trend
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
2020
2024
Equity ratio
21.0%
This company
38.2%
Market median
-45% vs market
2020
2024
Return on equity
27.0%
This company
18.4%
Market median
+47% vs market
2020
2024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
2020
2024
Asset turnover
2.59×
This company
1.12×
Market median
+131% vs market
2020
2024
Debt / equity
3.77×
This company
0.62×
Market median
-508% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on GlaxoSmithKline Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
